Cellectric Biosciences

Cellectric has developed the world’s first lab tool addressing the cell’s electrome – it’s electric fingerprint. We envision our platform to become the future standard for any cell-based workflow in life-sciences, offering a simple, automated and highly precise alternative to biochemical processes. Our unfair advantage is based on a patented electrodynamic cell manipulation technology that enables binary cell specificity in a flow-through, cartridge-based benchtop device. In our beachhead vertical, we isolate cell populations of interest for company partners in diagnostics and cell therapy. We are currently raising seed funding toward first commercial traction in the space of infection diagnosis, to proliferate our MVP to additional pilot customers and to prepare upscaling the production of our cartridge consumable.